Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
about
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Efficacy of Sym004 in Patients ...... e 2 Randomized Clinical Trial.
@en
Efficacy of Sym004 in Patients ...... e 2 Randomized Clinical Trial.
@nl
type
label
Efficacy of Sym004 in Patients ...... e 2 Randomized Clinical Trial.
@en
Efficacy of Sym004 in Patients ...... e 2 Randomized Clinical Trial.
@nl
prefLabel
Efficacy of Sym004 in Patients ...... e 2 Randomized Clinical Trial.
@en
Efficacy of Sym004 in Patients ...... e 2 Randomized Clinical Trial.
@nl
P2093
P2860
P50
P921
P1433
P1476
Efficacy of Sym004 in Patients ...... e 2 Randomized Clinical Trial.
@en
P2093
Ana Rovira
Antonio Cubillo
Clara Montagut
Cliff Ding
Cristina Nadal
Fortunato Ciardiello
Françoise Desseigne
Giulia Siravegna
Guglielmo Fumi
Guillem Argilés
P2860
P304
P356
10.1001/JAMAONCOL.2017.5245
P50
P577
2018-04-12T00:00:00Z